Search Results

An Interview With David L. Dawson, MD

Dr. Dawson discusses the future of endovascular simulation, drug therapies for intermittent claudication, and his experience as Chief of the Medical Sciences Division at the NASA Johnson Space Center.

Ischemic Limb Complications in the ICU

How to recognize and manage the risk factors and complications that can lead to limb ischemia in hospitalized patients.

By David L. Dawson, MD

Managing Iatrogenic Injury and Arteriovenous Fistulae

Covered or bare-metal stents may be useful options for treating perforation and arteriovenous fistulae complicating below-the-knee arterial interventions.

By David L. Dawson, MD

Next Frontiers in Simulation

A look at the new technology, what is on the horizon, and how medical simulation can be used as part of endovascular training.

By David L. Dawson, MD

The Benefits of Simulation Training for Fellows and Residents

Long used in aviation, simulation technology is emerging as a key component of graduate medical education programs.

By David L. Dawson, MD

Using Covered Stents in the Carotid Arteries

An overview of the potential uses for covered stents in this anatomy, including a review of the literature and procedural considerations.

By David L. Dawson, MD

Training With Endovascular Simulators in Graduate Medical Education Programs

There is a growing role for this technology, although specific applications and cost effectiveness are challenges to be overcome.

By David L. Dawson, MD

Utility of Procedural Checklists in SFA Interventions

The use of checklists can improve outcomes and ensure the safety and efficiency of endovascular SFA procedures.

By Michael S. Hong, MD, and David L. Dawson, MD

Covered Stents for Treating Aortoiliac Occlusive Disease

The use of covered stents as a novel technique for preventing and treating restenosis in the iliac arteries

By Andrew T. Kwa, MD; David L. Dawson, MD; and John R. Laird, MD

Options For Treating CLI

By John R. Laird, Jr, MD

Expanding the Role of Peripheral Endografts

By John R. Laird, Jr, MD, Chief Medical Editor

The Good, the Bad, and the Ugly

By John R. Laird, Jr, MD, Chief Medical Editor

Chief Medical Editor's Page

By John R. Laird, MD

Peripheral Embolic Protection

By John R. Laird, Jr, MD, Chief Medical Editor

The Ongoing Pursuit of Data

By John R. Laird, Jr, MD, Chief Medical Editor

Safety in SFA Intervention

By Marianne Brodmann, MD, and John R. Laird Jr, MD

Bivalirudin in Peripheral Interventions

Results from the APPROVE trial and the emerging role of “endopharmacology” in treating PVD.

By David E. Allie, MD; Patrick A. Hall, MD; Nicolas W. Shammas, MD; Robert Safian, MD; John R. Laird, Jr, MD; John J. Young, MD; and Ajay Virmani, MD